ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,057Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 1187

$620K Total Retail Price of All Prescriptions

Rank: 111 out of 1187

337 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 337 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

5% of this provider’s 337 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 10,089 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
LEVOTHYROXINE SODIUM 610 594 1 3
FUROSEMIDE 522 497 2 8
AMLODIPINE BESYLATE 423 382 3 2
OMEPRAZOLE 417 391 4 5
SIMVASTATIN 289 277 5 1
METOPROLOL TARTRATE 284 268 6 10
WARFARIN SODIUM 261 235 7 13
DIOVAN 248 241 8 17
METOPROLOL SUCCINATE 226 216 9 11
NAMENDA 197 197 10 44
ATORVASTATIN CALCIUM 190 177 11 6
DONEPEZIL HCL 187 187 12 26
ZOLPIDEM TARTRATE 159 122 13 14
DIGOXIN 157 157 14 65
SERTRALINE HCL 148 148 15 22
HYDROCHLOROTHIAZIDE 128 115 16 9
POTASSIUM CHLORIDE 124 124 17 32
JANUVIA 122 108 18 34
EXELON 109 109 19 132
LOSARTAN POTASSIUM 108 107 20 21
TRAMADOL HCL 104 103 21 28
PRAVASTATIN SODIUM 95 84 22 12
METFORMIN HCL 87 67 23 7
ESCITALOPRAM OXALATE 85 83 24 51
RISPERIDONE 81 81 25 58
MIRTAZAPINE 79 79 26 54
GABAPENTIN 79 64 26 23
CELEBREX 79 79 26 68
ATENOLOL 76 75 29 18
CITALOPRAM HBR 76 76 29 45
QUETIAPINE FUMARATE 74 74 31 75
HYDROCODONE-ACETAMINOPHEN 74 53 S3 31 20
DOXYCYCLINE HYCLATE 73 67 33 164
ALENDRONATE SODIUM 71 71 34 25
PREDNISONE 70 68 35 61
LISINOPRIL 68 68 36 4
DIVALPROEX SODIUM 67 67 37 79
CLOPIDOGREL 66 53 38 33
TRAZODONE HCL 66 49 38 63
FENTANYL 60 50 S2 40 82
CARBIDOPA-LEVODOPA 60 60 40 99
KLOR-CON M20 59 59 42 93
LACTULOSE 58 52 43 96
ENDOCET 55 16 S2 44 78
CARVEDILOL 54 49 45 19
GLYCOPYRROLATE 53 53 46 394
ADVAIR DISKUS 50 23 47 35
KLOR-CON M10 50 49 47 207
LEVOFLOXACIN 50 38 47 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 4, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.